United States Oncolytic Virotherapy Market Poised for Breakthrough Growth Amid Rising Cancer Treatment Innovations 2025 | Top key players - Amgen Inc, AstraZeneca, Oncorus, Inc.

Market Overview:

The Oncolytic Virotherapy Market is expected to grow at a CAGR of 23.07% during the forecasting period 2024-2031.

The Oncolytic Virotherapy Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/oncolytic-virotherapy-market?sz

The Oncolytic Virotherapy Market focuses on the development, production, and commercialization of viruses engineered to selectively infect and destroy cancer cells while sparing healthy tissues. This innovative immunotherapy approach leverages viral replication to trigger antitumor immune responses, offering potential treatment for various cancers. The market encompasses therapeutics, delivery technologies, clinical trials, and research-driven collaborations globally.

Industry Recent Developments:

USA:
In October 2025, the U.S. market is leading innovation with strong biotech financing and robust regulatory support, driving advancements in genetically engineered oncolytic viruses and clinical trial activity. Major cancer centers are combining oncolytic viruses with checkpoint inhibitors and CAR-T therapies to improve treatment efficacy.

In October 2025, North America, led by the U.S., continues to dominate due to well-established biotech ecosystems, government funding, and a strong focus on personalized virotherapies improving treatment precision and safety.

Japan:
In September 2025, Japan granted conditional approval for the herpes simplex virus (HSV)-based Teserapure for malignant glioma, signaling growing regulatory acceptance and clinical use of innovative oncolytic virotherapies.

In October 2025, the International Conference on Oncolytic Virus Therapeutics was held in Kyoto, Japan, highlighting advancements in clinical research, viral vector engineering, and fostering partnerships in the oncolytic virotherapy field.

Europe:
In September 2025, the European market is growing steadily supported by adaptive regulatory frameworks for advanced therapy medicinal products, collaborative cancer research networks, and strong biotech hubs in Germany and France focusing on precision medicine and innovative cancer treatment protocols.

In October 2025, France and Germany are positioned as key European players with ongoing public and private investments in cancer research, promoting access and early adoption of oncolytic virotherapy through supportive healthcare systems and clinical trial participation.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/oncolytic-virotherapy-market?sz

Major Key Players:

Amgen Inc
AstraZeneca
Shanghai Sunway Biotech Co., Ltd
TILT Biotherapeutics Ltd
Oncorus, Inc
Takara Bio Inc
Vyriad
Transgene SA
Lokon Pharma AB
Pfizer Inc
Roche.

Key Growth Drivers:

Rising prevalence of cancer worldwide, leading to increased demand for innovative, targeted cancer therapies.

Advances in genetic and viral engineering technologies that enhance the specificity, effectiveness, and safety of oncolytic viruses.

Supportive regulatory frameworks, increasing clinical trials, and growing collaborations between biotechnology firms and academic institutions accelerating development and commercialization.

Segments Covered in the Oncolytic Virotherapy Market:

By Therapy Type: Adenoviruses-based Oncolytic Viruses, HSV-based Oncolytic Viruses, Others.

By Application: Severe Atrophy of Maxillary Bone, Melanoma, Prostate Cancer, the Breast Cancer, Ovarian Cancer, Lung Cancer, Others.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=oncolytic-virotherapy-market

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Oncolytic Virotherapy market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Oncolytic Virotherapy Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The Global Oncolytic Virotherapy market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Oncolytic Virotherapy Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Oncolytic Virotherapy Market in 2025?
◆ What is the projected growth rate of the Oncolytic Virotherapy Market through 2033?
◆ Who are the key players in the Oncolytic Virotherapy Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.